Patent · US Active

Pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment

US12004506B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH · AT

Inventors

Hendrik Fischer · Wien, AT
Helmut Pietschmann · Waldbronn, DE
Susan Jane Tzotzos · Wien, AT
Bernhard Fischer · Wien, AT
Rudolf Lucas · Ekeren, BE

Key dates

Filing date	Jul 28, 2020
Grant date	Jun 11, 2024
Priority date	—
Expiry date	Jul 28, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K7/64
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A method of conditioning/improving lung functions extracorporeally by treatment of a non-ischemic donor lung ex vivo with a cyclized compound of the amino acid sequence of formula X1-GQRETPEGAEAKPWY-X2 I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.